Home
>>
Products
>>
Proteins
>>
Recombinant Proteins
>
Recombinant Human FLT3LG Protein, His Tag

Recombinant Human FLT3LG Protein, His Tag

Product Number

KRP699

Alias

P36888, Flt-3 Ligand, CD135, FLK-2, FLK2, STK1

Specifications
  • 100ug
  • 500ug
  • 1mg
Product Description
AliasP36888, Flt-3 Ligand, CD135, FLK-2, FLK2, STK1
Catalog NumberKRP699
Product IntroductionRecombinant human Flt-3 ligand is a key growth factor for the development of dendritic cells and hematopoietic stem cells. Mainly used for in vitro generation of dendritic cells, immunotherapy research, and hematopoietic expansion experiments.
Molecular NameFLT3LG
SpeciesHuman
HostSf9 Cells
Size100ug,500ug,1mg
Purity>95%, determined by SDS-PAGE.
ConcentrationContact the sales manager to obtain the concentration of the latest batch.
PurificationAffinity Purification
Endotoxin<0.1 EU/μg, determined by LAL method.
BackgroundA ligand for Flt-3 receptor (CD135), important for proliferation and differentiation of hematopoietic stem cells and dendritic cell precursors, studied as a mobilizer of dendritic cells in immunotherapy.
ApplicationWB, ELISA
Predicted Molecular Weight17.5 kDa
ReconstitutionIt is recommended that the lyophilized human Flt-3 Ligand protein be dissolved in PBS at a concentration of 100-200 μg/ml for further dilution as the working concentration.
Storage ConditionSamples are stable for up to twelve months from date of receipt at -20℃ to -103℃. Avoid repeated freeze-thaw cycles.
Shipping ConditionThis product is shipped on ice packs or dry ice.
StabilityRepeated freezing and thawing is not recommended.
Molecular Weight17­30 kDa,
Uniprot IDP49771
References1. Wodnar­Filipowicz, A. (2003) News Physiol. Sci. 18:247. 2. Dong, J. et al. (2002) Cancer Biol. Ther. 1:486. 3. Gilliland, D.G. and J.D. Griffin (2002) Blood 100:1532. 4. Hannum, C. et al. (1994) Nature 368:643. 5. Lyman, S.D. et al. (1994) Blood 83:2795. 6. Lyman, S.D. et al. (1993) Cell 75:1157. 7. Savvides, S.N. et al. (2000) Nat. Struct. Biol. 7:486. 8. McClanahan, T. et al. (1996) Blood 88:3371. 9. Diener, K.R. et al. (2008) Exp. Hematol. 36:51. 10. Farag, S.S. and M.A. Caligiuri (2006) Blood Rev. 20:123. 11. Edwan, J.H. et al. (2004) J. Immunol. 172:5016.1. Wodnar­Filipowicz, A. (2003) News Physiol. Sci. 18:247. 2. Dong, J. et al. (2002) Cancer Biol. Ther. 1:486. 3. Gilliland, D.G. and J.D. Griffin (2002) Blood 100:1532. 4. Hannum, C. et al. (1994) Nature 368:643. 5. Lyman, S.D. et al. (1994) Blood 83:2795. 6. Lyman, S.D. et al. (1993) Cell 75:1157. 7. Savvides, S.N. et al. (2000) Nat. Struct. Biol. 7:486. 8. McClanahan, T. et al. (1996) Blood 88:3371. 9. Diener, K.R. et al. (2008) Exp. Hematol. 36:51. 10. Farag, S.S. and M.A. Caligiuri (2006) Blood Rev. 20:123. 11. Edwan, J.H. et al. (2004) J. Immunol. 172:5016.
FunctionRecombinant Human Flt-3 Ligand is a key growth factor for the development of dendritic cells and hematopoietic stem cells. It is primarily used for the in vitro generation of dendritic cells, research on immunotherapy, and hematopoietic expansion experiments.
Product DeclarationThis product is for research use only and must not be used directly on the human body or for injection.
Temperature RangeStore the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -43℃. Avoid repeated freeze-thaw cycles.
Product Full NameRecombinant Human Flt-3 Ligand Protein
TargetFlt-3
FAQ
  • What are the targets of FLT3 ligand?

    It acts on hematopoietic stem/progenitor cells expressing the Flt3 receptor (CD135), which is crucial for their proliferation and survival.

  • Why is it the core of hematopoietic expansion protocols?

    Because it specifically supports the most primitive hematopoietic stem/progenitor cells, and the combination of SCF and TPO is the golden combination for the in vitro efficient expansion of hematopoietic stem cells and progenitor cells.

Login

Don’t have an account?Sign Up Now

Register

Already have an account?Log In Now

Inquire Now